Then the efficacy of AKT3 on alveolar hypercoagulation and fibrinolytic inhibition, and the relationship between RUNX1 and AKT3 in regulating alveolar hypercoagulation and fibrinolytic inhibition in LPS-induced ARDS were all thoroughly studied. Here, AKT3 is linked to acute respiratory distress syndrome.